查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1392067

主動脈瓣狹窄市場：依類型、主動脈瓣類型、嚴重程度、依最終用戶、地區

Aortic Stenosis Market, By Type, By Aortic Valve Types (Mechanical Aortic Valves and Bioprosthetic Aortic Valves), By Severity, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球主動脈瓣狹窄市場規模預計將從 2023 年的 83.3 億美元增至 2030 年的 167.7 億美元，預測期內複合年成長率為 10.5%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 83.3億美元
實績資料 2018-2021 預測期 2023-2030
預測期複合年成長率 10.50% 2030年市場規模預測 167.7億美元
圖 1. 2023 年依地區分類的主動脈瓣狹窄全球市場佔有率(%)
主動脈瓣狹窄市場-IMG1

主動脈瓣狹窄是分隔左心室和主動脈的主動脈瓣開口變窄。它阻止血液從心臟流向主動脈（主動脈），從而減少心臟主泵室每次收縮時被泵送到身體的血液量。主動脈瓣狹窄經過多年緩慢發展，階段無症狀，但隨著病情變得更加嚴重，就會出現症狀。隨著瓣膜孔口變得越來越窄，心臟必須更加努力才能透過受限的瓣膜孔口泵出足夠的血液，從而給心臟帶來額外的壓力。如果不進行治療，最終會削弱並損害心肌。

市場動態

高血壓、肥胖和糖尿病等危險因子的盛行率不斷上升，對全球主動脈瓣狹窄市場的成長做出了重大貢獻。主動脈瓣狹窄的常見原因包括老齡化、主動脈瓣鈣沉積導致其僵硬、風濕熱和主動脈瓣先天性畸形。高齡化、技術進步和意識的提高預計將在預測期內推動全球主動脈瓣狹窄市場的成長。此外，醫療保健支出的增加預計也將推動預測期內全球主動脈瓣狹窄市場的成長。經導管主動脈瓣置換術（TAVR）的擴展、新興市場的治療和藥物開拓、個人化醫療、遠端醫療和遠距監測將為預測期內的全球主動脈瓣狹窄市場提供成長機會。

然而，高昂的治療成本、限制性的報銷政策、可得性和意識障礙以及臨床和手術併發症預計將阻礙預測期內主動脈瓣狹窄市場的成長。

本研究的主要特點

  • 本報告對全球主動脈瓣狹窄市場進行了詳細分析，並提出了以2022年為基準年的預測期（2023-2030年）的市場規模和年複合成長率（CAGR%）。
  • 該報告還揭示了各個區隔市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
  • 該報告還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 該報告根據公司亮點、產品系列、主要亮點、業績和策略等參數，介紹了全球主動脈瓣狹窄市場的主要企業。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的資訊。
  • 全球主動脈瓣狹窄市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
  • 透過用於分析全球主動脈瓣狹窄市場的各種策略矩陣，將促進相關人員的決策。

目錄

第1章 研究目的與假設

  • 研究目標
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

  • 市場動態
    • 老年人口
    • 昂貴的治療費用
    • 經導管主動脈瓣置換術(TAVR) 擴張
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 管道分析
  • 波特的分析
  • 併購場景

第4章全球主動脈瓣狹窄市場 - 冠狀冠狀病毒(COVID-19) 大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章全球主動脈瓣狹窄市場，依類型，2018-2030

  • 介紹
  • 先天性主動脈瓣狹窄
  • 後天主動脈瓣狹窄

第 6 章 2018-2030 年全球主動脈瓣狹窄市場（依主動脈瓣類型）

  • 介紹
  • 機械主動脈瓣
  • 生物人工（組織）主動脈瓣

第 7 章 全球主動脈瓣狹窄市場（依嚴重程度），2018-2030 年

  • 介紹
  • 輕度主動脈瓣狹窄
  • 中度主動脈瓣狹窄
  • 嚴重主動脈瓣狹窄

第 8 章全球主動脈瓣狹窄市場，依最終用戶分類，2018-2030 年

  • 介紹
  • 醫院
  • 診所
  • 門診手術中心
  • 其他

第9章2018-2030年全球主動脈瓣狹窄市場（依地區）

  • 介紹
  • 北美洲
  • 美國
  • 加拿大
  • 雨美國
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 東南亞國協
  • 其他亞太地區
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章競爭形勢

  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova PLC
  • CryoLife, Inc
  • Braile Biomedica
  • JenaValve Technology, Inc
  • Meril Life Sciences Pvt. Ltd
  • Micro Interventional Devices, Inc
  • egnite, Inc.

第11章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6129

The Global Aortic Stenosis Market size is expected to reach US$ 16.77 billion by 2030, from US$ 8.33 billion in 2023, at a CAGR of 10.5% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 8.33 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 10.50% 2030 Value Projection: US$ 16.77 Bn
Figure 1. Global Aortic Stenosis Market Share (%), By Region, 2023
Aortic Stenosis Market - IMG1

Aortic stenosis is a narrowing of the aortic valve opening that divides the left ventricle from the aorta. It obstructs the blood flow from the heart into the main artery (aorta) and reduces the amount of blood pumped out to the body with each contraction of the heart's main pumping chamber. Aortic stenosis progression can occur slowly over many years and asymptomatic in early stages, with symptoms developing as it becomes more severe. As the valve opening narrows further, the heart must work harder to pump enough blood through the restricted opening, putting extra strain on the heart. This can eventually weaken and damage the heart muscle if not treated.

Market Dynamics

The rising prevalence of risk factors such as high blood pressure, obesity and diabetes is significantly contributing to the growth of the global aortic stenosis market. Some of the common causes of aortic stenosis include aging, deposits of calcium on the aortic valve which makes it stiff, rheumatic fever and congenital malformations of the aortic valve. Aging population, technological advancements, and increasing awareness are anticipated to drive growth of the global aortic stenosis market over the forecast period. Moreover, rising healthcare expenditure is also expected to boost the growth of the global aortic stenosis market over the forecast period. Transcatheter aortic valve replacement (TAVR) expansion, emerging therapies and novel drug development, personalized medicine, and telemedicine and remote monitoring are expected to create growth opportunities for the global aortic stenosis market during the forecast period.

However, high cost of treatment, limited reimbursement policies, availability and awareness barriers, and clinical and procedural complications are expected to hamper growth of the aortic stenosis market over the forecast period.

Key features of the study:

  • This report provides an in-depth analysis of the global aortic stenosis market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global aortic stenosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, CryoLife, Inc., Braile Biomedica, JenaValve Technology, Inc., Meril Life Sciences Pvt. Ltd., Micro Interventional Devices, Inc., and egnite, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global aortic stenosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aortic stenosis market

Global Aortic Stenosis Market Detailed Segmentation:

  • By Type:
    • Congenital Aortic Stenosis
    • Acquired Aortic Stenosis
  • By Aortic Valve Types:
    • Mechanical Aortic Valves
    • Bioprosthetic (Tissue) Aortic Valves
  • By Severity:
    • Mild Aortic Stenosis
    • Moderate Aortic Stenosis
    • Severe Aortic Stenosis
  • By End User:
    • Hospital
    • Clinics
    • Ambulatory Surgical Centers
    • Others
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profile:
    • Edwards Lifesciences Corporation
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • LivaNova PLC
    • CryoLife, Inc.
    • Braile Biomedica
    • JenaValve Technology, Inc.
    • Meril Life Sciences Pvt. Ltd.
    • Micro Interventional Devices, Inc.
    • gnite, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Aortic Valve Types
    • Market Snapshot, By Severity
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Aging Population
    • High Cost of Treatment
    • Transcatheter Aortic Valve Replacement (TAVR) Expansion
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • Pipeline Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Aortic Stenosis Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Aortic Stenosis Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Congenital Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Acquired Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Aortic Stenosis Market, By Aortic Valve Types, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Mechanical Aortic Valves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Bioprosthetic (Tissue) Aortic Valves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Aortic Stenosis Market, By Severity, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Mild Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Moderate Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Severe Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Aortic Stenosis Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

9. Global Aortic Stenosis Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2018-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • U.S.
  • Canada
  • Lain America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Edwards Lifesciences Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • LivaNova PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • CryoLife, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Braile Biomedica
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • JenaValve Technology, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Meril Life Sciences Pvt. Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Micro Interventional Devices, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • egnite, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us